ALPS Advisors’s RayzeBio, Inc. Common Stock RYZB Stock Holding History

ALPS Advisors’s Portfolio RYZB Stock Details RYZB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-41,539	Closed	-$2.58M	–	1088
2023 Q4	$2.58M	Buy	+41,539	New	+$1.03M	0.02%	304

ALPS Advisors's RYZB Position: Q1 2024 in Review

ALPS Advisors sold out of RayzeBio, Inc. Common Stock (RYZB) in Q1 2024, closing a stake of 41,539 shares — an estimated $2.58M sold.

ALPS Advisors first reported a position in RYZB in Q4 2023 and held it in 1 quarter. The position peaked at $2.58M in Q4 2023. 0 funds tracked by Wall St. Rank hold RYZB as of Q1 2024.

ALPS Advisors reported no remaining RayzeBio, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
ALPS Advisors sold 41,539 RayzeBio, Inc. Common Stock shares in Q1 2024, an estimated $2.58M.
ALPS Advisors first reported a position in RayzeBio, Inc. Common Stock in Q4 2023 and held it in 1 quarter.
ALPS Advisors's RayzeBio, Inc. Common Stock position peaked at $2.58M in Q4 2023.
0 funds tracked by Wall St. Rank held RayzeBio, Inc. Common Stock as of Q1 2024.

Based on ALPS Advisors's 13F filing for Q1 2024, filed 14 May 2024.